963
Participants
Start Date
September 30, 2007
Primary Completion Date
March 27, 2017
Study Completion Date
March 27, 2017
Mount Sinai Medical Center, New York
Weill Cornell University, Washington D.C.
Roswell Park, Buffalo
University of Pennsylvania, Philadelphia
University of Georgetown, Washington D.C.
Johns Hopkins, Baltimore
University of Florence, Florence
University of Illinois at Chicago, Chicago
University of Utah, Salt Lake City
Palo Alto Medical Foundation Research Institute, Palo Alto
Ospedali Riuniti di Bergamo, Bergamo
Myeloproliferative Disorders-Research Consortium
NETWORK
National Cancer Institute (NCI)
NIH
Icahn School of Medicine at Mount Sinai
OTHER